Trials / Completed
CompletedNCT06184334
Management of OAB in Female Patients .
Assessment of Efficacy of Mirabegron, Solifenacin, Tadalafil 5mg and Combination Therapy in Female Patients With Overactive Bladder: A Double Blinded Prospective Randomized Placebo -Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- Elsayed Abdelhalim Elsayed · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to compare the effectiveness of mirabegron, solifenacin, tadalafil (5mg), and their combination in relieving symptoms of overactive bladder (OAB) in a double-blinded prospective randomized placebo-controlled trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Solfenacin | pills taken once day |
| DRUG | Mirabegron | pills taken once day |
| DRUG | Tadalafil 5mg | pills taken once day |
Timeline
- Start date
- 2022-09-14
- Primary completion
- 2022-12-01
- Completion
- 2023-12-01
- First posted
- 2023-12-28
- Last updated
- 2024-04-02
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06184334. Inclusion in this directory is not an endorsement.